Diagnostic performance of GENEDIA W and ActiveXpress+ COVID-19 antigens tests among symptomatic individuals in Peru and The United Kingdom.
Sandra Palomino-PadillaLorna FinchMargaretha de VosHelen R SavageLuz Villa-CastilloGail HaywardEloïse Cooknull nullnull nullnull nullCamille EscadafalRichard BodyEmily R AdamsCesar Ugarte-GilAna I Cubas-AtienzarPublished in: PloS one (2023)
Whilst the overall clinical sensitivity of the Genedia did not meet WHO minimum performance requirements for rapid immunoassays in either cohort, the ActiveXpress+ did so for the small UK cohort. This study illustrates comparative performance of Ag-RDTs across two global settings and considers the different approaches in evaluation methods.